Hutton Scott Insider Trading Activity

Summary

Updated Jul 16, 2026

Hutton Scott is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $70K.

Profile

Scott Hutton is the President and CEO of Biodesix Inc, a company specializing in diagnostic solutions for lung disease. He has held this position since the company's focus on providing diagnostic testing services, including blood-based lung and COVID tests.

Role	Insider
Notability	30/100

Board memberships

Biodesix Inc

Awards & honors

Leadership in diagnostic solutions
Focus on lung disease diagnostics
Development of blood-based testing services

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-02-24	BDSX	BIODESIX INC	S — Open-market sale	1.5K	$12.78	$19K
2026-02-24	BDSX	BIODESIX INC	M — Option exercise	4.8K	—
2026-02-11	BDSX	BIODESIX INC	S — Open-market sale	3.6K	$10.08	$36K
2026-02-11	BDSX	BIODESIX INC	M — Option exercise	10.0K	—
2026-01-20	BDSX	BIODESIX INC	S — Open-market sale	970	$8.15	$8K
2026-01-20	BDSX	BIODESIX INC	M — Option exercise	2.6K	—
2025-08-12	BDSX	BIODESIX INC	S — Open-market sale	3.8K	$0.42	$2K
2025-08-12	BDSX	BIODESIX INC	M — Option exercise	12.2K	—
2024-11-13	BDSX	BIODESIX INC	S — Open-market sale	1.8K	$1.40	$3K
2024-11-13	BDSX	BIODESIX INC	S — Open-market sale	1.9K	$1.39	$3K
2024-11-13	BDSX	BIODESIX INC	M — Option exercise	12.2K	—

Frequently Asked Questions

Who is Hutton Scott?

Has Hutton Scott been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 6 open-market sales ($70K) across all tracked filings.

Where can I see all of Hutton Scott's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Hutton Scott — SEC Form 4 Insider Trading Activity